Patents Assigned to Novo Nordisk HelathCare A/G
  • Nucleic acids encoding human coagulation factor VII variants
    Patent number: 7416860
    Abstract: The invention concerns nucleic acids encoding coagulation Factor VII variants in which the Leu residue in position 305 has been replaced by another amino acid residue. The invention further concerns the expression of such nucleic acids resulting in a Factor VII variant having increased biological activity.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: August 26, 2008
    Assignee: Novo Nordisk HelathCare A/G
    Inventors: Egon Persson, Ole Hvilsted Olsen
  • Human coagulation factor VII polypeptides
    Publication number: 20050204411
    Abstract: The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: April 21, 2005
    Publication date: September 15, 2005
    Applicant: Novo Nordisk HelathCare A/G
    Inventors: Egon Persson, Ole Olsen